Business / Tags / Breast

BUSINESS / NEWS Mon Jun 2, 2008 @ 8:16am neoform

BusinessWeek -- AstraZeneca's Iressa took an FDA hit in 2005 as a lung cancer treatment, but a recent study showed its potential in breast cancer patients There may be a second life for Iressa, AstraZeneca's once-promising cancer drug that came to symbolize the hype s.. Read More

BUSINESS / NEWS Tue Feb 26, 2008 @ 8:11am neoform

BusinessWeek -- The FDA approval of the breast cancer treatment, which was opposed by advisory panels, shocked patients, doctors, and investors When the Food & Drug Administration announced late on Feb. 22 that it had swept aside the objections of its expert advisers.. Read More